BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34951690)

  • 1. Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma.
    Şahin S; Ertekin E; Şahin T; Özsunar Y
    MAGMA; 2022 Feb; 35(1):153-162. PubMed ID: 34951690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors.
    Cho NS; Hagiwara A; Sanvito F; Ellingson BM
    Neuroradiology; 2023 Mar; 65(3):559-568. PubMed ID: 36301349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
    Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
    J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
    Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
    BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma.
    Stecco A; Pisani C; Quarta R; Brambilla M; Masini L; Beldì D; Zizzari S; Fossaceca R; Krengli M; Carriero A
    J Neurooncol; 2011 Apr; 102(2):261-71. PubMed ID: 20658351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
    Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
    Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG).
    Qin L; Li A; Qu J; Reinshagen K; Li X; Cheng SC; Bryant A; Young GS
    J Neurooncol; 2018 Apr; 137(2):313-319. PubMed ID: 29383647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion.
    Morana G; Tortora D; Staglianò S; Nozza P; Mascelli S; Severino M; Piatelli G; Consales A; Lequin M; Garrè ML; Rossi A
    Neuroradiology; 2018 Apr; 60(4):437-446. PubMed ID: 29453753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy of Arterial Spin Labeling in Comparison With Dynamic Susceptibility Contrast-Enhanced Perfusion for Brain Tumor Surveillance at 3T MRI.
    Lavrova A; Teunissen WHT; Warnert EAH; van den Bent M; Smits M
    Front Oncol; 2022; 12():849657. PubMed ID: 35669426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery.
    Ma H; Wang Z; Xu K; Shao Z; Yang C; Xu P; Liu X; Hu C; Lu X; Rong Y
    Exp Ther Med; 2017 Jun; 13(6):2691-2698. PubMed ID: 28587332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
    Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
    Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
    Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
    Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma.
    Ulmer S; Liess C; Kesari S; Otto N; Straube T; Jansen O
    J Neurooncol; 2009 Jan; 91(2):213-20. PubMed ID: 18807224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme.
    Jovanovic M; Radenkovic S; Stosic-Opincal T; Lavrnic S; Gavrilovic S; Lazovic-Popovic B; Soldatovic I; Maksimovic R
    J BUON; 2017; 22(4):1061-1067. PubMed ID: 28952228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics.
    Prah MA; Al-Gizawiy MM; Mueller WM; Cochran EJ; Hoffmann RG; Connelly JM; Schmainda KM
    J Neurooncol; 2018 Jan; 136(1):13-21. PubMed ID: 28900832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.
    Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC
    Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion magnetic resonance imaging of normal-appearing white matter in multiple sclerosis: correlation with brain volume and clinical disability.
    Larassati H; Pandelaki J; Estiasari R; Prihartono J; Firdausia S; Yunus RE; Mulyadi R
    J Cent Nerv Syst Dis; 2022; 14():11795735221098147. PubMed ID: 35572123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.